Merck out, Merck in
This article was originally published in Scrip
Elmar Schnee, head of Merck KGaA's pharmaceuticals unit, is stepping down to be replaced by the head of emerging markets at US rival Merck & Co, Stefan Oschmann. Mr Schnee was said to be leaving "for personal reasons". In line with his predecessor, Mr Oschmann will be responsible for both the Merck Serono and Consumer Health Care divisions of the German firm. Merck KGaA has suffered a series of clinical setbacks of late. Last month, the US FDA extended its review period for the company's multiple sclerosis pill cladribine, which was rejected by the EU's CHMP in September.